Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-18-001595
Filing Date
2018-02-07
Accepted
2018-02-07 15:18:28
Documents
1
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form5.html 5  
1 form5.xml 5 7779
  Complete submission text file 0001493152-18-001595.txt   10049
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578
Business Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578 208-263-6695
10X Fund, L.P. (Reporting) CIK: 0001453356 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 001-31791 | Film No.: 18580901

Mailing Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578
Business Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578 850-502-7659
10X Capital Management, LLC (Reporting) CIK: 0001457247 (see all company filings)

State of Incorp.: FL | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 001-31791 | Film No.: 18580900